[ From Briefing 9:25AM ] Cancer Genetics (CGIX) signed an in-network provider agreement with the healthcare network Blue Cross Blue Shield of Minnesota. As part of the agreement, the over 2.6 million members of the Blue Cross Blue Shield plan will have access to CGI's cancer diagnostics and genomic testing services.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.